AIGENE INC — Department of Defense SBIR Phase I: AFX235-CSO1

AIGENE INC — SBIR Phase I award from Department of Defense.

Amount
$74,620
Agency
Department of Defense · Air Force
Program / Phase
SBIR · Phase I
Topic
AFX235-CSO1
Solicitation
X23.5
NAICS
Place of performance
CO
Period
2023-05-05 → 2023-08-07

Description

Cancer kills 600,000 every year in the US, more than any disease except heart disease, yet we have no single blood test for it. It accounts for nearly 40% of patients who have treatment costs of $200-300k per year, yet we have no generally applicable, rap